Sign Up to like & get
recommendations!
0
Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-01532-7
Abstract: To evaluate the influence of patient-associated parameters and comorbities, with a special focus on renal function after intravesical adjuvant bacillus Calmette-Gue´rin (BCG) immunotherapy in patients with non–muscle-invasive bladder cancer (NMIBC). We retrospectively reviewed the medical…
read more here.
Keywords:
recurrence;
muscle invasive;
non muscle;
renal function ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2022-005518
Abstract: Background BCG is recommended as intravesical immunotherapy to reduce the risk of tumor recurrence in patients with non-muscle invasive bladder cancer (NMIBC). Currently, it is unknown whether intravesical BCG application induces trained immunity. Methods The…
read more here.
Keywords:
intravesical bcg;
trained immunity;
induces trained;
bcg ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Thorax"
DOI: 10.1136/thoraxjnl-2017-210634
Abstract: Amy Gray (Junior Doctor) : An 88-year-old man with a background of transitional cell bladder cancer diagnosed in 2012 was referred to the ambulatory care clinic with a 1-month history of increasing breathlessness. He had constitutional symptoms…
read more here.
Keywords:
left sided;
pleural effusion;
sided pleural;
effusion ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Urologia internationalis"
DOI: 10.1159/000528740
Abstract: INTRODUCTION In this study, we aimed to explore using the predictive role of systemic immune inflammation index (SII) for responses of intravesical Bacillus Calmette-Guérin (BCG) therapy in patients with intermediate- and high-risk non-muscle-invasive bladder cancer…
read more here.
Keywords:
intermediate high;
intravesical bcg;
high risk;
sii ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Translational Medicine"
DOI: 10.1186/s12967-019-1778-6
Abstract: BackgroundWe set out to determine if the administration of subcutaneous (SQ) ALT-803 was non-inferior to standard intravesical BCG treatment in a carcinogen induced mouse (C57BL/6J) bladder cancer model.MethodsUsing this well-established carcinogen induced mouse model, we…
read more here.
Keywords:
803 alone;
bladder;
model;
alt 803 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Revista da Associacao Medica Brasileira"
DOI: 10.1590/1806-9282.66.s2.91
Abstract: INTRODUCTION In this retrospective study, we aimed to investigate the frequency of COVID-19 in patients with and without BCG application due to bladder tumors. METHODS The presence of COVID-19 was investigated in 167 patients with…
read more here.
Keywords:
frequency covid;
covid patients;
intravesical bcg;
covid ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Spine Surgery and Related Research"
DOI: 10.22603/ssrr.2022-0009
Abstract: Figure 1-a. Sagittal plane computed tomography (CT) scan at first visit. CT shows osteolytic lesion on T9–T10. The arrow marks T9. Fig. 1-b Sagittal magnetic resonance imaging (MRI) images at first visit. Left: T1-weighted image.…
read more here.
Keywords:
bcg therapy;
calmette rin;
intravesical bcg;
rin spondylodiscitis ... See more keywords